These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro fertilization and multiple pregnancies: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488 [TBL] [Abstract][Full Text] [Related]
5. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Youssef MA; Mourad S Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848 [TBL] [Abstract][Full Text] [Related]
6. Fresh versus frozen embryo transfers in assisted reproduction. Wong KM; van Wely M; Mol F; Repping S; Mastenbroek S Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011184. PubMed ID: 28349510 [TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904 [TBL] [Abstract][Full Text] [Related]
9. Fresh versus frozen embryo transfers in assisted reproduction. Zaat T; Zagers M; Mol F; Goddijn M; van Wely M; Mastenbroek S Cochrane Database Syst Rev; 2021 Feb; 2(2):CD011184. PubMed ID: 33539543 [TBL] [Abstract][Full Text] [Related]
10. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618 [TBL] [Abstract][Full Text] [Related]
11. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Luke B; Brown MB; Morbeck DE; Hudson SB; Coddington CC; Stern JE Fertil Steril; 2010 Sep; 94(4):1399-1404. PubMed ID: 19591989 [TBL] [Abstract][Full Text] [Related]
12. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Macedo CR Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006105. PubMed ID: 25406011 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI. Sun B; Ma Y; Li L; Hu L; Wang F; Zhang Y; Dai S; Sun Y Front Endocrinol (Lausanne); 2020; 11():615957. PubMed ID: 33542709 [TBL] [Abstract][Full Text] [Related]
14. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198 [TBL] [Abstract][Full Text] [Related]
15. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816 [TBL] [Abstract][Full Text] [Related]